Quick answer yes they would if they were calculated. But the true median OS in Cvac group will never be calculated because the protocol cuts the data analysis off at five years.
But your question illustrates the absurdity of whats going on here. If the patients in the Cvac group are young and new treatments are good the median survival just keeps getting better and better into all of time
.
- Forums
- ASX - By Stock
- IMM
- Statistics of the Clinical Trials
Statistics of the Clinical Trials, page-18
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
30.5¢ |
Change
-0.015(4.69%) |
Mkt cap ! $443.0M |
Open | High | Low | Value | Volume |
31.5¢ | 31.5¢ | 29.8¢ | $1.010M | 3.293M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 54974 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 142219 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 37712 | 0.305 |
29 | 540305 | 0.300 |
11 | 243669 | 0.295 |
24 | 683400 | 0.290 |
14 | 151275 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 101059 | 11 |
0.315 | 163552 | 9 |
0.320 | 97000 | 8 |
0.325 | 205793 | 8 |
0.330 | 391031 | 7 |
Last trade - 11.51am 16/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online